Flagship pioneering board of directors
WebJan 3, 2024 · David R. Epstein is executive partner at Flagship Pioneering and executive chairman of Flagship-founded Rubius Therapeutics. Most recently, he served as chief executive officer of Novartis Pharmaceuticals, a division of Novartis AG, from 2010 to mid-2016. Previously, David started up and led Novartis’ Oncology and Molecular Diagnostic … WebChairman of the Board of Directors. Stephen Berenson is a Managing Partner at Flagship Pioneering and member of the firm’s Resource Allocation and Management Committees. Prior to Flagship, Mr. …
Flagship pioneering board of directors
Did you know?
WebFeb 27, 2024 · The top shareholders of Moderna are Robert S. Langer, Stéphane Bancel, Noubar B. Afeyan, Baillie Gifford & Company, and Flagship Pioneering Inc. In mid-March 2024, Moderna began testing its COVID ... WebAug 23, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 23, 2024-- Axcella Health Inc. (Nasdaq: AXLA), a biotechnology company pioneering the research and development of novel multifactorial interventions using novel compositions of endogenous metabolic modulators to address dysregulated metabolism and support health, today announced …
WebAug 6, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Aug. 6, 2024-- Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the appointment of Stephen Berenson to its Board of Directors. Mr. Berenson is a Managing Partner at Flagship Pioneering and previously spent his career as an investment banker at J.P. Morgan. WebDec 28, 2024 · Harvard/MIT Cooperative Society. May 2024 - Present3 years 11 months. Cambridge, Massachusetts, United States. …
WebJun 14, 2024 · CAMBRIDGE, Mass., June 14, 2024 — Moderna Therapeutics, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Paul Sagan has joined the company’s Board of Directors.Mr. Sagan … WebInari Agriculture (a Flagship Pioneering company) Sep 2024 - Present 3 years 8 months. Cambridge, MA Owner Pierre-Etienne Boin Management & Consulting ... Member of the Board of Directors Member ...
WebPaul Peter Tak, MD PhD FMedSci, Professor of Medicine. 2024 PharmaVOICE100 honoree (100 most inspiring people in life sciences). …
WebMay 24, 2016 · BEDFORD, Mass.--(BUSINESS WIRE)--Joule, a leading low carbon fuels company, today announced the appointment of William J. Brady Jr. to the company’s board of directors. Mr. Brady is an industry leader who brings extensive experience from his 25-year career at top-tier renewable fuels and chemicals companies. how many uk laws are thereWebJan 31, 2024 · CAMBRIDGE, Mass., January 30, 2024 -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and biotech leader Christian Schade is joining as Growth Partner. ... in New York and London for both Merrill Lynch and JP Morgan Chase & Co. Schade currently serves as chair of the board of directors of … how many uk fit in russiaWebJul 27, 2024 · Slaoui was Chairman of GSK’s Pipeline Investment Board (PIB) between 2006 and 2015 and served as a Director of GSK from 2006 to 2024. He currently serves as Chairman of the Board of Galvani, a bioelectronics-dedicated biotech co-owned by GSK and Verily, an Alphabet company. Dr. Slaoui previously was a member of the Advisory … how many uk graduates do graduate schemesWebMar 23, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Mar. 23, 2024-- Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the appointment of Paul Biondi, Executive Partner at Flagship Pioneering, to its Board of Directors. how many uk housing associationsWebNov 12, 2024 · KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts. For more information, please visit the company’s website at www.ksqtx.com. KSQ Contact Michael Lampe Tel: 484-575-5040 [email protected] how many uk homesWebMar 14, 2024 · CAMBRIDGE, Mass. — March 14, 2024— Torque, an immuno-oncology company developing Deep Primed™ cell therapeutics with pharmacologic control to drive a full immune response within the tumor microenvironment, announced today the appointment of John Hohneker, MD, to the Board of Directors and Marcela Maus, MD, PhD, to the … how many uk have had covidWebFlagship Pioneering Jun 2024 - Present5 years 11 months Cambridge, Massachusetts Capital formation, value growth and realization, strategic … how many uk mp\u0027s are there